Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. APRE.NASDAQ

Aprea Therapeutics Inc (APRE NASDAQ) stock market data APIs

$3.84 -0.12(-3%) as of July 26, 2024
Price chart is built with Anychart

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Aprea Therapeutics Inc Financial Data Overview

3.96
3.84
-
3.96
3.8
2.95-8.8465
21 504 K
5 430 K
964 K
-0.67
1.921
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'APRE',
Type: 'Common Stock',
Name: 'Aprea Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Q6Q3K37',
ISIN: NULL,
CUSIP: NULL,
CIK: '1781983',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-10-03',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Aprea Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 964 K
  • EBITDA -13 986 331
  • Earnings Per Share -3.28
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Aprea Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.78

Get Aprea Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Aprea Therapeutics Inc latest news via APIs

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

DOYLESTOWN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncol...
  • APREA THERAPEUTICS
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:APRE

Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways

DOYLESTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncolo...
  • APREA THERAPEUTICS
  • CALENDAR OF EVENTS
  • NASDAQ:APRE
Do you have any questions?
support@eodhistoricaldata.com